The five-hospital system reported a $110.4 million operating loss in the period ending Dec. 31. The nine-month loss compared with operating income of $28.6 million in the same period ending March 31, 2022.
Expenses rose almost 10 percent for the system, which saw some of its bonds downgraded to an “A” rating April 6 by S&P Global.
Improved non-operating income offered some relief, with an overall loss totaling $101.8 million compared to net income of $10.5 million in the same period ending March 31, 2022.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
